ARTICLE | Company News
Merz sales and marketing update
September 27, 2010 7:00 AM UTC
Merz's Merz Pharma Canada launched the AXcess Advantage Program for Xeomin incobotulinumtoxinA in Canada that will pay up to 20% of a patient's out of pocket prescription expenses. The botulinum neur...